LOMBARD MED INC - COM (EVAR)

CUSIP: G55598109

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
12,206,927
Share change
+575,104
Total reported value
$7,271,000
Price per share
$0.60
Number of holders
8
Value change
+$169,285
Number of buys
2
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP G55598109?
CUSIP G55598109 identifies EVAR - LOMBARD MED INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LOMBARD MED INC - COM (EVAR) as of Q4 2016

As of 31 Dec 2016, LOMBARD MED INC - COM (EVAR) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,206,927 shares. The largest 8 holders included Invesco Ltd., Abingworth LLP, SV Life Sciences Advisers, LLC, New Leaf Venture Partners, L.L.C., UBS Group AG, GOLDMAN SACHS GROUP INC, HSBC HOLDINGS PLC, and MORGAN STANLEY. This page lists 8 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.